Table 2 Possibly-Related Adverse Events in the Safety Population
From: Daptomycin Therapy for Osteomyelitis: A Retrospective Study
Adverse Event | N (%) | Serious | Action Taken | Resolution |
|---|---|---|---|---|
Blood CPK Increased | 8 (11) | No | None | Resolved |
No | None | Resolved | ||
No | None | Resolved | ||
No | None | Resolved | ||
No | None | Resolved | ||
No | None | Resolved | ||
No | None | Unknown | ||
Yes | Dose Reduced | Resolved | ||
Diarrhea | 3 (4) | No | None | Unknown |
None | Resolved | |||
Stopped Permanently | Resolved | |||
Rash | 2 (3) | No | Stopped Permanently | Resolved |
Chills | 1 (1) | No | Stopped Permanently | Resolved |
Nausea | 1 (1) | No | None | Resolved |
Photosensitivity Reaction | 1 (1) | No | Stopped Temporarily | Resolved |
Pyrexia | 1 (1) | No | Stopped Permanently | Resolved |